Literature DB >> 12547726

Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.

Anne Tierens1, Jan Delabie, Agnieszka Malecka, Junbai Wang, Alicja Gruszka-Westwood, Daniel Catovsky, Estella Matutes.   

Abstract

Splenic marginal zone lymphoma (also splenic lymphoma with villous lymphocytes) is a B-cell non-Hodgkin's lymphoma with a characteristic morphology and phenotype. We studied the pattern of somatic hypermutation of the rearranged immunoglobulin heavy chain genes on 23 cases and have correlated these data with survival as well as immunophenotypic and genetic characteristics of the cases. Two-thirds of the cases show immunoglobulin gene mutations, half of which show evidence of antigen selection, whereas one-third of the cases show no significant mutations. On-going mutation, a feature characteristic of follicular lymphoma, was demonstrated in all six cases randomly selected for this analysis, including one case with a low number of mutations (<2%). No statistical significant correlation was found between immunoglobulin mutation status and clinical, immunophenotypic, or genetic characteristics. Our results demonstrate that on-going somatic hypermutation is a prominent feature of splenic marginal zone lymphoma with circulating villous lymphocytes. On-going somatic hypermutation has previously been demonstrated in extra-nodal and nodal marginal zone lymphoma. Our results indicate that marginal zone lymphomas at different anatomical localizations may derive from a similar B-cell subset.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547726      PMCID: PMC1851160          DOI: 10.1016/S0002-9440(10)63862-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes.

Authors:  A Conconi; F Bertoni; E Pedrinis; T Motta; E Roggero; S Luminari; C Capella; M Bonato; F Cavalli; E Zucca
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

2.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  p53 abnormalities in splenic lymphoma with villous lymphocytes.

Authors:  A M Gruszka-Westwood; R A Hamoudi; E Matutes; E Tuset; D Catovsky
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

4.  Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study.

Authors:  X Troussard; L Mauvieux; I Radford-Weiss; K Rack; F Valensi; R Garand; M Vekemans; G Flandrin; E A Macintyre
Journal:  Br J Haematol       Date:  1998-06       Impact factor: 6.998

5.  CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.

Authors:  S Weller; A Faili; C Garcia; M C Braun; F Le Deist F; G de Saint Basile G; O Hermine; A Fischer; C A Reynaud; J C Weill
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling.

Authors:  H Gary-Gouy; P Bruhns; C Schmitt; A Dalloul; M Daëron; G Bismuth
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

7.  Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.

Authors:  J M Hernández; J L García; N C Gutiérrez; M Mollejo; J A Martínez-Climent; T Flores; M B González; M A Piris; J F San Miguel
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 8.  The role of CD5-expressing B cells in health and disease (review).

Authors:  J O Pers; C Jamin; F Predine-Hug; P Lydyard; P Youinou
Journal:  Int J Mol Med       Date:  1999-03       Impact factor: 4.101

9.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

Authors:  Patricia Algara; Marisol S Mateo; Margarita Sanchez-Beato; Manuela Mollejo; Immaculada C Navas; Lourdes Romero; Francesc Solé; Marta Salido; Lourdes Florensa; Pedro Martínez; Elias Campo; Miguel A Piris
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

10.  Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.

Authors:  D K Dunn-Walters; L Boursier; J Spencer; P G Isaacson
Journal:  Hum Pathol       Date:  1998-06       Impact factor: 3.466

View more
  6 in total

1.  Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.

Authors:  Silvia Zibellini; Daniela Capello; Francesco Forconi; Paolo Marcatili; Davide Rossi; Sara Rattotti; Silvia Franceschetti; Elisa Sozzi; Emanuele Cencini; Roberto Marasca; Luca Baldini; Alessandra Tucci; Francesco Bertoni; Francesco Passamonti; Ester Orlandi; Marzia Varettoni; Michele Merli; Silvia Rizzi; Valter Gattei; Anna Tramontano; Marco Paulli; Gianluca Gaidano; Luca Arcaini
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

2.  A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.

Authors:  Xiaofeng Shi; Rong Ba; Haiyan You; Qian Jiang; Jiansong Huang; Jianhua Mao; Lanxiu Han; Shuo Zhang; Qin Zhuang; Xianqiu Yu; Lixia Wang; Yun Wang; Dongya Li; Wei Zhu; Yong Zhang; Yan Zhu; Xiaodong Xi
Journal:  Front Med       Date:  2017-10-27       Impact factor: 4.592

3.  Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma.

Authors:  Amer Zeidan; Bishoy Faltas; Patrick Forde; Andrea Subhawong; Celeste Bello; Javier Bolaños-Meade
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-05

4.  Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Authors:  Gunhild Trøen; Vigdis Nygaard; Tor-Kristian Jenssen; Ida Münster Ikonomou; Anne Tierens; Estella Matutes; Alicja Gruszka-Westwood; Daniel Catovsky; Ola Myklebost; Grete Lauritzsen; Eivind Hovig; Jan Delabie
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

Review 5.  Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.

Authors:  Sarah H Walsh; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Theodora Papadaki; Evangelia Kalagiakou; Niki Stavroyianni; Vassiliki Douka; Stavroula Afendaki; Riad Saloum; Aikaterini Parasi; Dimitra Anagnostou; Nikolaos Laoutaris; Athanasios Fassas; Achilles Anagnostopoulos
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.